Report Overview
The Global Gynecomastia Procedures Market size is expected to be worth around US$ 2.5 Billion by 2035 from US$ 1.0 Billion in 2025, growing at a CAGR of 9.4% during the forecast period 2026-2035. In 2025, North America led the market, achieving over 41.6% share with a revenue of US$ 0.4 Billion.
Gynecomastia is a common condition characterized by the enlargement of male breast tissue, affecting men of all ages due to hormonal changes, genetics, certain medications, or underlying health conditions. While the condition is generally non-cancerous, it can lead to physical discomfort and significantly impact self-confidence and emotional well-being.
Modern gynecomastia procedures offer safe and effective solutions to restore a more masculine chest contour. Treatment options are broadly categorized into surgical and non-surgical procedures, depending on the severity of the condition and individual patient needs. Surgical interventions, including liposuction and glandular tissue excision, remain the most preferred approach for achieving long-lasting and natural-looking results. Non-surgical treatments, such as lifestyle modifications and hormone-based therapies, may be suitable for select cases.
Advancements in cosmetic and reconstructive surgery techniques have improved patient outcomes by minimizing scarring, reducing recovery time, and enhancing overall satisfaction. These procedures are typically performed in hospitals, specialty clinics, and cosmetic surgery centers by qualified healthcare professionals.
With growing awareness of male aesthetic health and increasing acceptance of cosmetic procedures, the demand for gynecomastia treatments continues to rise globally. The availability of advanced technologies and personalized treatment plans is enabling more individuals to seek effective solutions, contributing to the expansion of the gynecomastia procedures market and improving quality of life for patients worldwide.
Click here for more information: https://market.us/report/gynecomastia-procedures-market/
Key Takeaways
Market Size (2025): Valued at US$ 1.0 Billion.
Growth Forecast: Expected to reach US$ 2.5 Billion by 2035, growing at a CAGR of 9.4%.
By Procedure Type: Surgical procedures dominated the market with a 72.8% share.
By Grade Type: Grade II accounted for the largest share at 34.6%.
By End User: Hospitals led the market, contributing 43.5% of total revenue.
Regional Analysis: North America held the leading position with a 41.6% market share.
Key Market Segments
By Procedure Type
Surgical Procedures
Liposuction-Assisted Mastectomy
Excision Surgery (Glandular Removal)
Laser-Assisted Liposuction
Ultrasound-Assisted Liposuction (UAL/VASER)
Others (Power-Assisted, RF-Assisted)
Non-Surgical Procedures
Hormonal Therapy
Radiation Therapy
Medication-Based Treatment
Others
By Grade Type
Grade I
Grade II
Grade III
Grade IV
By End User
Hospitals
Specialty Clinics
Ambulatory Surgical Centers (ASCs)
Cosmetic Surgery Centers
Others
Top Key Players
MicroAire Surgical Instruments
Lumenis (Lumenis Be)
Aesthetic Group
Candela Corporation
Cutera
Cynosure (Cynosure Lutronic)
Solta Medical (Bausch Health)
Sientra
Emerging Trends
Rising Preference for Minimally Invasive Procedures: Healthcare providers are increasingly adopting minimally invasive gynecomastia procedures that combine liposuction with small-incision gland removal. These techniques reduce scarring, shorten recovery time, and improve patient satisfaction. According to Mayo Clinic, liposuction and limited mastectomy are commonly used surgical options for persistent gynecomastia, allowing patients to resume normal activities faster than traditional open surgery.
Growing Awareness Among Adolescents and Young Adults: Gynecomastia awareness is increasing due to better health education and social media discussions about male body image. Clinical research shows that pubertal gynecomastia affects approximately 50–65% of adolescent boys, although most cases resolve naturally within two years. This awareness is encouraging early medical consultation and timely treatment when necessary.
Increased Demand for Personalized Treatment Plans: Healthcare specialists now emphasize individualized treatment based on hormone levels, age, medications, and underlying health conditions. Mayo Clinic recommends comprehensive medical evaluation before surgery because gynecomastia may result from hormonal imbalance, medications, obesity, or endocrine disorders. This personalized approach improves treatment success and reduces unnecessary surgical interventions.
Expansion of Outpatient Surgical Care: Many gynecomastia procedures are shifting from inpatient hospitals to outpatient settings due to advances in anesthesia and surgical techniques. Small-incision surgery and liposuction enable patients to return home on the same day, lowering healthcare costs and improving convenience while maintaining high standards of patient safety.
Strong Focus on Mental Health and Quality of Life: Healthcare organizations increasingly recognize the psychological impact of gynecomastia, including reduced confidence and social anxiety. Studies highlight that the condition can significantly affect emotional well-being, especially in adolescents. As a result, treatment plans now often include counseling and patient education alongside medical or surgical management, creating a more holistic care approach.
Key Use Cases
Persistent Pubertal Gynecomastia Treatment: Surgical procedures are widely used for adolescents and young adults whose breast enlargement persists beyond the normal observation period. Mayo Clinic notes that most pubertal cases resolve within 6 months to 2 years, while persistent cases with pain or emotional distress may require surgery to restore chest appearance and confidence.
Management of Age-Related Gynecomastia: Gynecomastia procedures are increasingly performed in older men experiencing hormonal changes. Mayo Clinic estimates that approximately 24%–65% of men aged 50–80 years may develop gynecomastia, making corrective procedures an important option for improving physical comfort and body image in this population.
Correction of Medication-Induced Breast Enlargement: Several prescription medications, including certain anti-androgens and cardiovascular drugs, can cause gynecomastia. After medical evaluation and medication review, surgical intervention may be considered when breast enlargement persists, helping patients regain a normal chest contour and improving quality of life.
Treatment for Hormonal and Endocrine Disorders: Gynecomastia procedures are used in patients with endocrine conditions such as hypogonadism or thyroid disorders when medical management alone is insufficient. Surgery complements hormone treatment by removing excess glandular tissue, providing long-term physical improvement while underlying hormonal issues continue to be managed clinically.
Cosmetic Body Contouring and Confidence Enhancement: An increasing number of men seek gynecomastia procedures to achieve a flatter and more masculine chest appearance. Modern liposuction and gland excision techniques offer natural-looking results with minimal scars, making these procedures valuable for improving self-esteem, clothing fit, and overall body image after appropriate medical assessment.
Conclusion: The global gynecomastia procedures market is poised for steady growth, driven by increasing awareness of male aesthetic health, technological advancements, and the rising adoption of minimally invasive surgical techniques. Growing demand for personalized treatment plans, outpatient procedures, and improved cosmetic outcomes is further supporting market expansion. Surgical procedures continue to dominate due to their long-lasting results, while hospitals remain the leading end users owing to their advanced infrastructure and specialized expertise. North America maintains a strong market position, supported by high healthcare spending and early adoption of innovative technologies. Overall, the market is expected to witness sustained growth as patient acceptance and access to effective gynecomastia treatments continue to improve worldwide.
Top comments (0)